Abiomed Inc (ABMD) - Financial and Strategic SWOT Analysis Review

Date: December 6, 2016
Pages: 51
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: A29B9EEDCFBEN
Leaflet:

Download PDF Leaflet

Abiomed Inc (ABMD) - Financial and Strategic SWOT Analysis Review
Abiomed Inc (ABMD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Abiomed Inc (Abiomed) is a provider of mechanical circulatory support devices. It undertakes the development, manufacture and marketing of novel technologies designed to replace or assist the pumping function of the failing heart. The company’s heart support and recovery product portfolio includes catheters for circulatory support; minimally invasive implantable cardiac assist devices; as well as percutaneous catheter-based devices including micro heart pumps, expandable catheter pumps and axial flow pumps. Abiomed also offer automated controllers, designed to control and monitor the catheter performance and display real time hemodynamic and catheter position information. It manufactures products in Danvers, Massachusetts; and Aachen, Germany. Abiomed is headquartered in Danvers, Massachusetts, the US.

Abiomed Inc Key Recent Developments

Oct 27, 2016: Abiomed Announces Q2 FY 2017 Revenue of $103 Million, Up 35% Over Prior Year
Oct 27, 2016: Amedisys Previews Third Quarter 2016 Results
Oct 25, 2016: Abiomed’s Impella Technology Showcased at TCT 2016 With More Than 25 Presentations During Scientific Sessions
Aug 11, 2016: Abiomed Outlines Long-Term Growth Strategy and Unveils Future Products at Annual Investor Conference
Jul 28, 2016: Abiomed Announces Q1 FY 2017 Revenue of $103.0 Million, Up 40% Over Prior Year

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

    Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

    Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

    Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

    Note: Some sections may be missing if data is unavailable for the company
  • SECTION 1 - ABOUT THE COMPANY

    Abiomed Inc - Key Facts
    Abiomed Inc - Key Employees
    Abiomed Inc - Key Employee Biographies
    Abiomed Inc - Major Products and Services
    Abiomed Inc - Medical Equipment Pipeline Products Data
    Abiomed Inc Pipeline Products by Equipment Type
    Abiomed Inc Pipeline Products by Development Stage
    Abiomed Inc - History
    Abiomed Inc - Company Statement
    Abiomed Inc - Locations And Subsidiaries
    Head Office
    Other Locations & Subsidiaries

    SECTION 2 – COMPANY ANALYSIS

    Abiomed Inc - Business Description
    Abiomed Inc - Corporate Strategy
    Abiomed Inc - SWOT Analysis
    SWOT Analysis - Overview
    Abiomed Inc - Strengths
    Abiomed Inc - Weaknesses
    Abiomed Inc - Opportunities
    Abiomed Inc - Threats
    Abiomed Inc - Key Competitors

    SECTION 3 – COMPANY FINANCIAL RATIOS

    Financial Ratios - Capital Market Ratios
    Financial Ratios - Annual Ratios
    Performance Chart
    Financial Performance
    Financial Ratios - Interim Ratios
    Financial Ratios - Ratio Charts

    SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

    Abiomed Inc, Medical Equipment, Deals By Year, 2010 to YTD 2016
    Abiomed Inc, Medical Equipment, Deals By Type, 2010 to YTD 2016
    Abiomed Inc, Recent Deals Summary

    SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

    Oct 27, 2016: Abiomed Announces Q2 FY 2017 Revenue of $103 Million, Up 35% Over Prior Year
    Oct 27, 2016: Amedisys Previews Third Quarter 2016 Results
    Oct 25, 2016: Abiomed’s Impella Technology Showcased at TCT 2016 With More Than 25 Presentations During Scientific Sessions
    Aug 11, 2016: Abiomed Outlines Long-Term Growth Strategy and Unveils Future Products at Annual Investor Conference
    Jul 28, 2016: Abiomed Announces Q1 FY 2017 Revenue of $103.0 Million, Up 40% Over Prior Year
    May 03, 2016: Abiomed Announces Q4 FY 2016 Revenue of $94.0 Million, Up 39% Over Prior Year
    Apr 12, 2016: Abiomed Impella Devices Support 37,673 Patients, Enough to Fill Historic Fenway Park
    Apr 07, 2016: Abiomed Impella Therapy Receives FDA Approval for Cardiogenic Shock After Heart Attack or Heart Surgery
    Feb 08, 2016: Abiomed Announces Appointments of Jeannine Rivet and Christopher Van Gorder to Board of Directors
    Feb 04, 2016: Abiomed Announces Q3 FY 2016 Revenue of $85.8 Million, Up 38% Over Prior Year

    SECTION 6 – APPENDIX

    Methodology
    Ratio Definitions
    About GlobalData
    Contact Us
    Disclaimer

    LIST OF TABLES

    Abiomed Inc, Key Facts
    Abiomed Inc, Key Employees
    Abiomed Inc, Key Employee Biographies
    Abiomed Inc, Major Products and Services
    Abiomed Inc Pipeline Products by Equipment Type
    Abiomed Inc Number of Pipeline Products by Development Stage
    Abiomed Inc Pipeline Products Summary by Development Stage
    Abiomed Inc, History
    Abiomed Inc, Subsidiaries
    Abiomed Inc, Key Competitors
    Abiomed Inc, Ratios based on current share price
    Abiomed Inc, Annual Ratios
    Abiomed Inc (Cont...1), Annual Ratios
    Abiomed Inc, Interim Ratios
    Abiomed Inc, Medical Equipment, Deals By Year, 2010 to YTD 2016
    Abiomed Inc, Medical Equipment, Deals By Type, 2010 to YTD 2016
    Abiomed Inc, Recent Deals Summary
    Currency Codes
    Capital Market Ratios
    Equity Ratios
    Profitability Ratios
    Cost Ratios
    Liquidity Ratios
    Leverage Ratios
    Efficiency Ratios

    LIST OF FIGURES

    Abiomed Inc Pipeline Products by Equipment Type
    Abiomed Inc Pipeline Products by Development Stage
    Abiomed Inc, Performance Chart (2012 - 2016)
    Abiomed Inc, Ratio Charts
    Abiomed Inc, Medical Equipment, Deals By Year, 2010 to YTD 2016
    Abiomed Inc, Medical Equipment, Deals by Type, 2010 to YTD 2016
    Skip to top


    Ask Your Question

    Abiomed Inc (ABMD) - Financial and Strategic SWOT Analysis Review
    Company name*:
    Contact person*:
    Phone/fax*:
    Email*:
    Request invoice
    Your enquiry:
    Please click on a Check Box below to confirm you are not a robot: